• 1
    Pacak, K., Eisenhofer, G., Ahlman, H. et al. (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nature clinical practice Endocrinology & metabolism, 3, 92102.
  • 2
    Darr, R., Lenders, J.W., Hofbauer, L.C. et al. (2012) Pheochromocytoma – update on disease management. Therapeutic Advances in Endocrinology and Metabolism, 3, 1126.
  • 3
    Chen, H., Sippel, R.S., O'Dorisio, M.S. et al. (2010) The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas, 39, 775783.
  • 4
    Brouwers, F.M., Eisenhofer, G., Lenders, J.W. et al. (2006) Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. Endocrinology and metabolism clinics of North America, 35, 699724. viii.
  • 5
    Newell, K.A., Prinz, R.A., Pickleman, J. et al. (1988) Pheochromocytoma multisystem crisis. A surgical emergency. Archives of Surgery, 123, 956959.
  • 6
    Scholten, A., Cisco, R.M., Vriens, M.R. et al. (2013) Pheochromocytoma crisis is not a surgical emergency. The Journal of Clinical Endocrinology and Metabolism, 98, 581591.
  • 7
    Guerrero, M.A., Schreinemakers, J.M., Vriens, M.R. et al. (2009) Clinical spectrum of pheochromocytoma. Journal of the American College of Surgeons, 209, 727732.
  • 8
    Moran, M.E., Rosenberg, D.J. & Zornow, D.H. (2006) Pheochromocytoma multisystem crisis. Urology, 67, e19e20.
  • 9
    Brouwers, F.M., Lenders, J.W., Eisenhofer, G. et al. (2003) Pheochromocytoma as an endocrine emergency. Reviews in Endocrine and Metabolic Disorders, 4, 121128.
  • 10
    Prejbisz, A., Lenders, J.W., Eisenhofer, G. et al. (2011) Cardiovascular manifestations of phaeochromocytoma. Journal of hypertension, 29, 20492060.
  • 11
    Subramanyam, S. & Kreisberg, R.A. (2012) Pheochromocytoma: a cause of ST-segment elevation myocardial infarction, transient left ventricular dysfunction, and takotsubo cardiomyopathy. Endocrine Practice, 18, e77e80.
  • 12
    Sojod, G., Diana, M., Wall, J. et al. (2012) Successful extracorporeal membrane oxygenation treatment for pheochromocytoma-induced acute cardiac failure. The American Journal of Emergency Medicine, 30, 1017 e1e3.
  • 13
    Yoshida, T. & Ishihara, H. (2009) Pheochromocytoma presenting as massive hemoptysis and acute respiratory failure. The American Journal of Emergency Medicine, 27, e3e4.
  • 14
    Kim, M.S., Muratore, C., Snelling, L. et al. (2009) Ischemic stroke and rhabdomyolysis in a 15-year-old girl with paraganglioma due to an SDHB exon 6 (Q214X) mutation. Journal of Pediatric Endocrinology and Metabolism, 22, 565571.
  • 15
    Bakar, B., Sumer, M.M. & Bulut, S. (2011) Pheochromocytoma presented with vertebral artery dissection. Brain Injury, 25, 11431146.
  • 16
    Majic, T. & Aiyagari, V. (2008) Cerebrovascular manifestations of pheochromocytoma and the implications of a missed diagnosis. Neurocritical care, 9, 378381.
  • 17
    Gu, L.Q., Zhao, L., Liu, J.M. et al. (2008) Phaeochromocytoma presenting with coexisting acute renal failure, acidosis and in hyperglycaemic emergency. British journal of biomedical science, 65, 153155.
  • 18
    Wu, H.W., Liou, W.P., Chou, C.C. et al. (2008) Pheochromocytoma presented as intestinal pseudo-obstruction and hyperamylasemia. The American Journal of Emergency Medicine, 26, e1e4.
  • 19
    Karri, V., Khan, S.L. & Wilson, Y. (2005) Bowel perforation as a presenting feature of pheochromocytoma: case report and literature review. Endocrine Practice, 11, 385388.
  • 20
    Zaludik, J., Schuitemaker, F., DeWaal, R. et al. (2010) Severe lactate acidosis and cardiogenic shock: a rare manifestation of a phaeochromocytoma. Anaesthesia and intensive care, 38, 593594.
  • 21
    Frankton, S., Baithun, S., Husain, E. et al. (2009) Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension. Hormones, 8, 6570.
  • 22
    Takahashi, N., Shimada, T., Tanabe, K. et al. (2011) Steroid-induced crisis and rhabdomyolysis in a patient with pheochromocytoma: a case report and review. International journal of cardiology, 146, e41e45.
  • 23
    Brauchlin, A.E., Rudiger, A., Bachli, E.B. et al. (2009) Portal vein thrombus and liver failure in a patient with pheochromocytoma crisis. The American Journal of Emergency Medicine, 27, e3e5.
  • 24
    O'Neal, P.B., Moore, F.D. Jr, Gawande, A. et al. (2012) Hemorrhagic shock as the initial manifestation of pheochromocytoma: report of a sequential management strategy. Endocrine Practice, 18, e81e84.
  • 25
    Lee, T.W., Lin, K.H., Chang, C.J. et al. (2013) Pheochromocytoma mimicking both acute coronary syndrome and sepsis: a case report. Medical Principles and Practice, 22, 405407.
  • 26
    Sheinberg, R., Gao, W.D., Wand, G. et al. (2012) Case 1–2012. A perfect storm: fatality resulting from metoclopramide unmasking a pheochromocytoma and its management. Journal of cardiothoracic and vascular anesthesia, 26, 161165.
  • 27
    Ritter, S., Guertler, T., Meier, C.A. et al. (2011) Cardiogenic shock due to pheochromocytoma rescued by extracorporeal membrane oxygenation. Interactive Cardiovascular and Thoracic Surgery, 13, 112113.
  • 28
    Davlouros, P.A., Velissaris, D., Tsiola, A. et al. (2010) Fever with multiple organ failure: not always sepsis. Anaesthesia and intensive care, 38, 10901093.
  • 29
    Abe, I., Nomura, M., Watanabe, M. et al. (2012) Pheochromocytoma crisis caused by Campylobacter fetus. International Journal of Urology, 19, 465467.
  • 30
    Hudsmith, J.G., Thomas, C.E. & Browne, D.A. (2006) Undiagnosed phaeochromocytoma mimicking severe preeclampsia in a pregnant woman at term. International Journal of Obstetric Anesthesia, 15, 240245.
  • 31
    Eisenhofer, G., Rivers, G., Rosas, A.L. et al. (2007) Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Safety, 30, 10311062.
  • 32
    Vanderveen, K.A., Thompson, S.M., Callstrom, M.R. et al. (2009) Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery, 146, 11581166.
  • 33
    Saxena, N. & Parry-Jones, A.J. (2008) Traumatic haemorrhage into an occult phaeochromocytoma: presentation and management in a patient with septic shock. Anaesthesia, 63, 428432.
  • 34
    Dabbous, A., Siddik-Sayyid, S. & Baraka, A. (2007) Catastrophic hemodynamic changes in a patient with undiagnosed pheochromocytoma undergoing abdominal hysterectomy. Anesthesia and analgesia, 104, 223224.
  • 35
    Sibal, L., Jovanovic, A., Agarwal, S.C. et al. (2006) Phaeochromocytomas presenting as acute crises after beta blockade therapy. Clinical endocrinology, 65, 186190.
  • 36
    Petrie, J., Lockie, C., Paolineli, A. et al. (2012) Undiagnosed phaeochromocytoma masquerading as eclampsia. BMJ Case Reports, 14.
  • 37
    Hosseinnezhad, A., Black, R.M., Aeddula, N.R. et al. (2011) Glucagon-induced pheochromocytoma crisis. Endocrine Practice, 17, e51e54.
  • 38
    Sizemore, G.W., Scrogin, K.E., Weisenberg, E.S. et al. (2008) Hypertensive crisis, catecholamine cardiomyopathy, and death associated with pseudoephedrine use in a patient with pheochromocytoma. Endocrine Practice, 14, 9396.
  • 39
    Rosas, A.L., Kasperlik-Zaluska, A.A., Papierska, L. et al. (2008) Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. European Journal of Endocrinology, 158, 423429.
  • 40
    Jan, T., Metzger, B.E. & Baumann, G. (1990) Epinephrine-producing pheochromocytoma with hypertensive crisis after corticotropin injection. The American Journal of Medicine, 89, 824825.
  • 41
    Ferguson, K.L. (1994) Imipramine-provoked paradoxical pheochromocytoma crisis: a case of cardiogenic shock. The American Journal of Emergency Medicine, 12, 190192.
  • 42
    Mamlouk, M.D., vanSonnenberg, E., Stringfellow, G. et al. (2009) Radiofrequency ablation and biopsy of metastatic pheochromocytoma: emphasizing safety issues and dangers. Journal of vascular and interventional radiology, 20, 670673.
  • 43
    Mitchell, L. & Bellis, F. (2007) Phaeochromocytoma–“the great mimic”: an unusual presentation. Emergency Medicine Journal, 24, 672673.
  • 44
    Nakano, S., Tsushima, Y., Taketomi-Takahashi, A. et al. (2011) Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma. Japanese Journal of Radiology, 29, 449451.
  • 45
    Sethi, P.S., Hiser, W., Gaffar, H. et al. (2008) Fatal pheochromocytoma crisis precipitated by dobutamine stress echocardiography. European Journal of Echocardiography, 9, 819821.
  • 46
    Ayala-Ramirez, M., Habra, M.A., Busaidy, N. et al. (2010) A catecholamine crisis on Mount Kilimanjaro: a hypoxia effect? Journal of Travel medicine, 17, 424426.
  • 47
    Gold, R.E., Wisinger, B.M., Geraci, A.R. et al. (1972) Hypertensive crisis as a result of adrenal venography in a patient with pheochromocytoma. Radiology, 102, 579580.
  • 48
    Baid, S.K., Lai, E.W., Wesley, R.A. et al. (2009) Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. Annals of internal medicine, 150, 2732.
  • 49
    Bessell-Browne, R. & O'Malley, M.E. (2007) CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR. American journal of roentgenology, 188, 970974.
  • 50
    Ganguly, P.K., Beamish, R.E. & Dhalla, N.S. (1989) Catecholamine cardiotoxicity in pheochromocytoma. American heart journal, 117, 13991400.
  • 51
    Lassnig, E., Weber, T., Auer, J. et al. (2009) Pheochromocytoma crisis presenting with shock and tako-tsubo-like cardiomyopathy. International journal of cardiology, 134, e138e140.
  • 52
    Kimura, S., Mitsuma, W., Ito, M. et al. (2010) Inverted Takotsubo contractile pattern caused by pheochromocytoma with tall upright T-waves, but not typical deep T-wave inversion. International journal of cardiology, 139, e15e17.
  • 53
    Galetta, F., Franzoni, F., Bernini, G. et al. (2010) Cardiovascular complications in patients with pheochromocytoma: a mini-review. Biomedicine & pharmacotherapy =. Biomedecine and Pharmacotherapie, 64, 505509.
  • 54
    Ueda, T., Oka, N., Matsumoto, A. et al. (2005) Pheochromocytoma presenting as recurrent hypotension and syncope. Internal medicine, 44, 222227.
  • 55
    de Leeuw, P.W., Waltman, F.L. & Birkenhager, W.H. (1986) Noncardiogenic pulmonary edema as the sole manifestation of pheochromocytoma. Hypertension, 8, 810812.
  • 56
    Graillon, T., Fuentes, S., Regis, J. et al. (2011) Multidisciplinary management of giant functional petrous bone paraganglioma. Acta Neurochirurgica, 153, 8589; discussion 9.
  • 57
    Annane, D., Vignon, P., Renault, A. et al. (2007) Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet, 370, 676684.
  • 58
    Kang, J.M., Lee, W.J., Kim, W.B. et al. (2005) Systemic inflammatory syndrome and hepatic inflammatory cell infiltration caused by an interleukin-6 producing pheochromocytoma. Endocrine journal, 52, 193198.
  • 59
    Minetto, M., Dovio, A., Ventura, M. et al. (2003) Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome. Journal of endocrinological investigation, 26, 453457.
  • 60
    Sauvage, M.R., Tulasne, P.A. & Arnaud, J.P. (1979) Hypertensive accident in a surgical patient with unsuspected pheochromocytoma (author's transl). Anesthesie, Analgesie, Reanimation, 36, 155158.
  • 61
    Uchida, N., Ishiguro, K., Suda, T. et al. (2010) Pheochromocytoma multisystem crisis successfully treated by emergency surgery: report of a case. Surgery today, 40, 990996.
  • 62
    Perel, P., Roberts, I. (2012) Colloids versus crystalloids for fluid resuscitation in critically ill patients. The Cochrane database of systematic reviews, 6, CD000567.
  • 63
    Dabrowska, B., Pruszczyk, P., Dabrowski, A. et al. (1995) Influence of alpha-adrenergic blockade on ventricular arrhythmias, QTc interval and heart rate variability in phaeochromocytoma. Journal of human hypertension, 9, 925929.
  • 64
    Bruynzeel, H., Feelders, R.A., Groenland, T.H. et al. (2010) Risk factors for hemodynamic instability during surgery for pheochromocytoma. The Journal of Clinical Endocrinology and Metabolism, 95, 678685.
  • 65
    van der Horst-Schrivers, A.N., Kerstens, M.N. & Wolffenbuttel, B.H. (2006) Preoperative pharmacological management of phaeochromocytoma. The Netherlands Journal of Medicine, 64, 290295.
  • 66
    Pacak, K. (2007) Preoperative management of the pheochromocytoma patient. The Journal of Clinical Endocrinology and Metabolism, 92, 40694079.
  • 67
    Protocol using oral phenoxybenzamine to prepare patients with catecholamine-secreting phaeochromocytoma and paraganglioma for surgery. (2010). Available from: (accessed 10 January 2013).
  • 68
    Banfi, C., Juthier, F., Ennezat, P.V. et al. (2012) Central extracorporeal life support in pheochromocytoma crisis. The Annals of Thoracic Surgery, 93, 13031305.
  • 69
    Proye, C., Thevenin, D., Cecat, P. et al. (1989) Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery, 106, 11491154.
  • 70
    Lord, M.S. & Augoustides, J.G. (2012) Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. Journal of cardiothoracic and vascular anesthesia, 26, 526531.
  • 71
    James, M.F. & Cronje, L. (2004) Pheochromocytoma crisis: the use of magnesium sulfate. Anesthesia and analgesia, 99, 680686, table of contents.
  • 72
    Morton, A. (2007) Magnesium sulphate for phaeochromocytoma crisis. Emergency Medicine Australasia, 19, 482.
  • 73
    NICE (2010) The management of hypertensive disorders during pregnancy: National Institute for Health and Clinical Excellence. CG107, August 2010. Available from: (accessed 9 April 2013).
  • 74
    Abdelwahab, W., Frishman, W. & Landau, A. (1995) Management of hypertensive urgencies and emergencies. Journal of clinical pharmacology, 35, 747762.
  • 75
    Chao, A., Yeh, Y.C., Yen, T.S. et al. (2008) Phaeochromocytoma crisis–a rare indication for extracorporeal membrane oxygenation. Anaesthesia, 63, 8688.
  • 76
    Park, S.M., Kim, D.H., Kwak, Y.T. et al. (2009) Pheochromocytoma-induced cardiogenic shock rescued by percutaneous cardiopulmonary bypass system. Circulation Journal, 73, 17531755.
  • 77
    Westaby, S., Shahir, A., Sadler, G. et al. (2009) Mechanical bridge to recovery in pheochromocytoma myocarditis. Nature Reviews Cardiology, 6, 482487.
  • 78
    Russell, J.A., Walley, K.R., Singer, J. et al. (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. The New England Journal of Medicine, 358, 877887.
  • 79
    Bergland, B.E. (1989) Pheochromocytoma presenting as shock. The American Journal of Emergency Medicine, 7, 4448.
  • 80
    Takagi, S., Miyazaki, S., Fujii, T. et al. (2000) Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma. Japanese circulation journal, 64, 785788.
  • 81
    Smet, M.C., Convens, C., Verherst, J. (1998) Successful use of an intra-aortic balloon pump in an acute phaeochromocytoma crisis with severe catecholamine cardiomyopathy. Clinical Intensive Care, 9, 167169.
  • 82
    Salinas, C.L., Gomez Beltran, O.D., Sanchez-Hidalgo, J.M. et al. (2011) Emergency adrenalectomy due to acute heart failure secondary to complicated pheochromocytoma: a case report. World Journal of Surgical Oncology, 9, 49.
  • 83
    Noorani, A., Vuylsteke, A., Lewis, C. et al. (2012) A moribund athlete. The Lancet, 380, 74.
  • 84
    Bos, J.C., Toorians, A.W., van Mourik, J.C. et al. (2003) Emergency resection of an extra-adrenal phaeochromocytoma: wrong or right? A case report and a review of literature. The Netherlands Journal of Medicine, 61, 258265.
  • 85
    Kinney, M.A., Narr, B.J. & Warner, M.A. (2002) Perioperative management of pheochromocytoma. Journal of cardiothoracic and vascular anesthesia, 16, 359369.
  • 86
    Newton, J.D., Munir, S., Bhindi, R. et al. (2008) What a headache: rare neuroendocrine indication for cardiopulmonary bypass for severe left ventricular dysfunction and shock. Circulation Heart failure, 1, 143145.